Dietrich Stephan

Dietrich Stephan

Chairman at Peptilogics, Inc.

Net worth: 107 173 $ as of 2024-03-30

54 year
Consumer Services
Health Technology
Commercial Services

Profile

Dietrich A.
Stephan
is the founder of Amnestix, Inc. (founded in 2006), Life Technologies Clinical Services Lab, Inc. (founded in 2006), Lifecode, Inc. (founded in 2011), and NeuBase Therapeutics, Inc. (founded in 2009).
He held the titles of Director-Neurogenomics Division at Amnestix, Inc., Director & Chief Scientific Officer at Life Technologies Clinical Services Lab, Inc., President, Chief Executive Officer & Director at Lifecode, Inc., and Chief Executive Officer & Director at NeuBase Therapeutics, Inc. Dr. Stephan was also the founder of DiaVacs, Inc., LifeX Holdings LLC.
His current job(s) include Chairman-Neuroscience Microarray Consortium at the National Institutes of Health, Chairman at Peptilogics, Inc., Director at FRX Growth Partners LLC, Director at Epistemix, Inc., Member at the National Institute of Health Policy, and Partner at Cyto Ventures.
His former job(s) include President & Chief Executive Officer at Neubase Therapeutics, Inc., Chairman-Neurogenomics Department & Professor at the Translational Genomics Research Institute, Director at Western Oncolytics Ltd., Executive Director-Gene Partnership at The Children's Hospital Corp.
and Harvard Medical School, Director at Personalized Medicine Coalition, Director at Sharp Edge Labs, Inc., Director at iGenomX International Genomics LLC, Director at Parabase Genomics, Inc., Director at Ariel Precision Medicine, Inc., Director at Pendulum Therapeutics, Inc., Director at CereDx, Inc., Professor at the University of Pittsburgh, Faculty Member at George Washington University, Arizona State University, The Johns Hopkins University, and the University of Arizona, and Chief Science Advisor at FarmaceuticalRX LLC.
His education includes an undergraduate degree from Carnegie Mellon University and a doctorate degree from the University of Pittsburgh Graduate School of Public Health.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-08-03 238,162 ( 6.39% ) 107 173 $ 2024-03-30

Dietrich Stephan active positions

CompaniesPositionStart
National Institute of Health Policy Corporate Officer/Principal -
Corporate Officer/Principal 2011-07-25
Chairman 2016-03-31
Cyto Ventures Corporate Officer/Principal -
Director/Board Member -
Director/Board Member -
All active positions of Dietrich Stephan

Former positions of Dietrich Stephan

CompaniesPositionEnd
NEUBASE THERAPEUTICS, INC. Chief Executive Officer 2024-01-15
Director/Board Member 2018-07-31
Founder 2011-03-31
░░░░░ ░░░░░░░░ ░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ -
░░░░░░░░░░ ░░ ░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
See the detail of Dietrich Stephan's experience

Training of Dietrich Stephan

Carnegie Mellon University Undergraduate Degree
University of Pittsburgh Graduate School of Public Health Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Dietrich Stephan's experience

Connections

100 +

1st degree connections

32

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies24

Health Technology

Health Technology

Health Technology

Health Services

Government

Commercial Services

Health Services

National Institute of Health Policy

Commercial Services

Commercial Services

Technology Services

Health Technology

Commercial Services

Health Services

Health Services

Health Technology

Process Industries

Health Technology

Process Industries

NeuBase Therapeutics, Inc.

LifeX Holdings LLC

Cyto Ventures

Commercial Services

Technology Services

See company connections
  1. Stock Market
  2. Insiders
  3. Dietrich Stephan